China vs Sur: Cases started on MDR-TB treatment
China
13,984
in 2024
Sur
10
in 2024
China rank
3rd
Sur rank
1st
Cases started on MDR-TB treatment over time
- China
- Sur
How they compare
China currently reports 13,984 against 10 in Sur, a difference of 13,974.
That makes China's figure about 1,398.4 times Sur's.
Across all 15 years both countries report, China has been ahead every year.
China ranks 3rd and Sur ranks 1st of 191 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 458 | 1 | 457 | China |
| 2010s | 5,291 | 0 | 5,291 | China |
| 2020s | 12,695 | 3.8 | 12,691 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, China or Sur?
- China, at 13,984 against 10 in Sur as of 2024.
- What is the difference in cases started on mdr-tb treatment between China and Sur?
- 13,974, with China ahead.
- How many years of comparable data are there for China and Sur?
- 15 years are reported by both, from 2009 to 2024.
- How do China and Sur rank globally for cases started on mdr-tb treatment?
- China ranks 3rd and Sur ranks 1st of 191 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.